SE0301798D0 - New use IV - Google Patents

New use IV

Info

Publication number
SE0301798D0
SE0301798D0 SE0301798A SE0301798A SE0301798D0 SE 0301798 D0 SE0301798 D0 SE 0301798D0 SE 0301798 A SE0301798 A SE 0301798A SE 0301798 A SE0301798 A SE 0301798A SE 0301798 D0 SE0301798 D0 SE 0301798D0
Authority
SE
Sweden
Prior art keywords
new use
functional
piperidyl
piperazinyl
substituted
Prior art date
Application number
SE0301798A
Other languages
Swedish (sv)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301798A priority Critical patent/SE0301798D0/en
Publication of SE0301798D0 publication Critical patent/SE0301798D0/en
Priority to PCT/SE2004/000962 priority patent/WO2004110447A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of piperidyl- or piperazinyl-substituted-1,2,3,4-tetrahydronaphthalene derivatives for the treatment of functional gastrointestinal disorders, such as functional dyspepsia.
SE0301798A 2003-06-19 2003-06-19 New use IV SE0301798D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301798A SE0301798D0 (en) 2003-06-19 2003-06-19 New use IV
PCT/SE2004/000962 WO2004110447A1 (en) 2003-06-19 2004-06-16 Use of tetrahydronaphtalene derivatives for treatment of gi disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301798A SE0301798D0 (en) 2003-06-19 2003-06-19 New use IV

Publications (1)

Publication Number Publication Date
SE0301798D0 true SE0301798D0 (en) 2003-06-19

Family

ID=27607363

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301798A SE0301798D0 (en) 2003-06-19 2003-06-19 New use IV

Country Status (2)

Country Link
SE (1) SE0301798D0 (en)
WO (1) WO2004110447A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197145T1 (en) * 1991-02-08 2000-11-15 Lilly Co Eli RING-SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRONAPHTAHLINE AND 3-AMINOCHROMANES
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9601110D0 (en) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9702799D0 (en) * 1997-07-25 1997-07-25 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2004110447A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
SE0202241D0 (en) Novel Compounds
SE0303180D0 (en) Novel compounds
SE0302232D0 (en) Novel Compounds
TW200510301A (en) Novel compounds
TW200407305A (en) Novel compounds
SE0301010D0 (en) Novel compounds
DK1881967T3 (en) Substituted benzo (D) isoaxol-3-yl-amine compounds as analgesics
SE0301009D0 (en) Novel compounds
IS2517B (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
NO20060230L (en) Novel aminobenzophenone compounds
MX2007011847A (en) Pyrimidindione derivatives as prokineticin 2 receptor antagonists.
NO20055741D0 (en) New chemical compounds
MX2007011695A (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof.
CY1108808T1 (en) MOTORCYCLE UNITS
DE602006010738D1 (en) PYRROLOÄ2,3-CÜPYRIDINDERIVATE
MX2007011698A (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof.
NO20055563L (en) Means for the treatment of lower abdominal disorders
TW200745039A (en) Isotopically substituted pantoprazole
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EA200600605A1 (en) REJUVENATED PENTANOLS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
UA106200C2 (en) Substituted oxindole-derivatives and use thereof for the treatment of vasopressin-dependent illnesses
EA200600404A1 (en) ORAL PREPARATIVE FORMS OF KLADRIBIN
NO20053562L (en) Novel aminobenzophenone compounds
EA200600115A1 (en) DERIVATIVES OF 2-AMINOBENZOIC ACID